Labroots’ virtual events enable individuals worldwide to connect and engage in groundbreaking scientific research from your ...

Discover upcoming breakthroughs in Type 1 Diabetes & B-cell disorder treatments, market growth to $24B by 2031, and key ...

Get our top picks of the posters at AACR 2025 and learn more about the method behind them and the techniques used.

Sana Biotechnology, Inc.’s SANA share price has dipped by 5.61%, which has investors questioning if this is right time to buy ...

The latest price target for Sana Biotechnology (NASDAQ:SANA) was reported by HC Wainwright & Co. on April 24, 2025. The analyst firm set a price target for $11.00 expecting SANA to rise to within ...

NEW YORK, May 5, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Sana Biotechnology, Inc. (NASDAQ: SANA). Shareholders who purchased shares of SANA during ...

NEW YORK, May 2, 2025 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical ... have been accepted for poster presentations at this conference in San Diego, CA.

(MENAFN- GlobeNewsWire - Nasdaq) NEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Sana Biotechnology, Inc. (NASDAQ: SANA). Shareholders ...

April 30, 2025--(BUSINESS WIRE)--PanGIA Biotech, a company advancing urine ... 3080), has been accepted for presentation in the poster session titled Developmental Therapeutics—Molecularly ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Sana is a biotechnology company that develops ex vivo and in vivo cell engineering programs to purportedly revolutionize treatment across a broad array of therapeutic areas with unmet treatment ...